Latest news

Our mission is to revolutionise synthetic gene synthesis to facilitate the fast-growing and exciting field of synthetic biology.

Evonetix shortlisted for Business Weekly awards

Evonetix shortlisted for Business Weekly awards

EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has been short-listed for the 2018 Business Weekly awards. The company has been short-listed for...

read more
Evonetix can be as big as Solexa, says Hauser

Evonetix can be as big as Solexa, says Hauser

When serial entrepreneur Hermann Hauser talks about companies with revolutionary technology on a global scale it is wise to listen. He has started many of them and backed a good deal more with hard cash. Having ‘fathered’ ARM and steered the superchip architect into...

read more
Evonetix announces the appointment of Dr Tim Brears as CEO

Evonetix announces the appointment of Dr Tim Brears as CEO

CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering a novel and disruptive approach to DNA synthesis, announced today the appointment of Dr Tim Brears as Chief Executive Officer. Tim previously served as Chief Executive of a number of...

read more
One in a billion

One in a billion

Cambridge Consultants spin-out Evonetix poised to transform synthetic biology industry. A breakthrough in DNA synthesis has led to the creation of a new spin-out company from the stable of product design and development firm Cambridge Consultants. The joint venture,...

read more